XML 25 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value Measurements - Additional Information (Detail)
3 Months Ended 9 Months Ended
Jun. 30, 2015
USD ($)
shares
Jun. 30, 2014
USD ($)
Jun. 30, 2015
USD ($)
shares
Jun. 30, 2014
USD ($)
Sep. 30, 2014
USD ($)
Jan. 31, 2013
shares
Dec. 31, 2012
shares
Jun. 30, 2010
shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]                
Short term investments | $ $ 23,280,640   $ 23,280,640   $ 21,653,032      
Investments | $ 1,085,282   1,085,282   23,088,346      
Total investments | $ 24,365,922   24,365,922   44,741,378      
Fair value of investment | $ $ 24,128,345   $ 24,128,345   $ 44,333,855      
Warrants outstanding 1,437,011   1,437,011          
Non-cash gain (loss) from change in fair value of the derivative liability | $ $ (102,763) $ 737,072 $ 2,268,798 $ (5,680,540)        
Duration of exchange rights     7 years          
Ablaris Therapeutics                
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]                
Warrants outstanding 500,000   500,000          
Non-cash gain (loss) from change in fair value of the derivative liability | $ $ (1,950) $ 21,397 $ 177,605 $ (31,791)        
Exchange right convertible conversion ratio for first year     0.06          
Exchange right convertible conversion ratio for second year     0.04          
Exchange right convertible conversion ratio for third year     0.03          
Exchange right convertible conversion ratio for fourth year     0.02          
Exchange right convertible conversion ratio for fifth year and beyond     0.01          
Number of exchange right sold     675,000          
2010 Warrants                
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]                
Warrants issued to acquire Common Stock               329,649
Warrants outstanding 24,324   24,324          
2012 Warrants                
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]                
Warrants issued to acquire Common Stock             912,543  
Warrants outstanding 265,161   265,161          
2013 Warrants                
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]                
Warrants issued to acquire Common Stock           833,530    
Warrants outstanding 12,123   12,123